Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2006071997) TREATMENT FOR CUTANEOUS METASTASES
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2006/071997 International Application No.: PCT/US2005/047467
Publication Date: 06.07.2006 International Filing Date: 30.12.2005
IPC:
A61K 39/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
Applicants:
BENNINGHOFF, Bernd [DE/DE]; DE (UsOnly)
HENGGE, Ulrich, R. [DE/DE]; DE (UsOnly)
3M INNOVATIVE PROPERTIES COMPANY [US/US]; 3M Center Post Office Box 33427 Saint Paul, Minnesota 55133-3427, US (AllExceptUS)
Inventors:
BENNINGHOFF, Bernd; DE
HENGGE, Ulrich, R.; DE
Agent:
GRAM, Christopher, D. ; 3M Center Office Of Intellectual Property Counsel Post Office Box 33427 Saint Paul, Minnesota 55133-3427, US
Priority Data:
60/640,49130.12.2004US
Title (EN) TREATMENT FOR CUTANEOUS METASTASES
(FR) TRAITEMENT DE METASTASES CUTANEES
Abstract:
(EN) The present invention provides methods for treating cutaneous metastases. In one aspect, the method can include identifying a treatment area that comprises one or more lesions containing metastatic cells; and administering an IRM compound to the treatment area in an amount effective for treating the lesion. In another aspect, the method can include identifying a treatment area that comprises one or more lesions containing metastatic cells; and administering a TLR7 agonist to the treatment area in an amount effective for treating the lesion. In another aspect, the method can include identifying a treatment area that comprises one or more lesions containing metastatic cells; and administering a TLR8 agonist to the treatment area in an amount effective for treating the lesion.
(FR) L'invention concerne des procédés de traitement de métastases cutanées. Selon un aspect, le procédé consiste à : identifier une zone de traitement qui comprend une ou plusieurs lésions à cellules métastatiques, et à administrer un composé modificateur de réponse immunitaire sur la zone en quantité efficace pour le traitement. Selon un autre aspect, le procédé consiste à : identifier une zone de traitement qui comprend une ou plusieurs lésions à cellules métastatiques, et à administrer un agoniste du TLR7 sur la zone en quantité efficace pour le traitement. Selon un autre aspect, le procédé consiste à identifier une zone de traitement qui comprend une ou plusieurs lésions à cellules métastatiques, et à administrer un agoniste du TLR8 sur la zone en quantité efficace pour le traitement.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)